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In this issue of the journal, Scholtens et al1 report of an absence of any correlation (r = 0.13, 
SEE = 54; P = .36) between hyperemic myocardial and peripheral blood flows during phar-
macological vasodilation with adenosine in a heterogenous group of patients and healthy 
volunteers as determined with 13N-ammonia PET. The study is unique in that it concurrently 
measured the blood flow increase or vasomotor response during pharmacologically induced 
vasodilation of the arteriolar resistance vessels in the myocardium and upper limb muscle. 
The current investigation agrees with earlier observations from Bottcher et al2 but extends 
them now also to the same stimulus to induce flow increases in the coronary and peripheral 
circulation. Bottcher et al2 were first to describe that the peripheral arterial flow responses to 
transient forearm ischemia did not correlate with dipyridamole-induced hyperemic myocardial 
blood flow increases. Thus, the current and previous investigations2 strongly suggest differ-
ent regulatory mechanisms of the coronary and peripheral microcirculations in the diseased 
and normal vascular states. Extrapolations between findings in the two vascular beds there-
fore may not necessarily apply. At the first sight, the results from Scholtens1 and those from 
Bottcher et al2 may indeed contrast the reported association between vascular function of 
the brachial and epicardial artery from a previous investigation conducted by Anderson et 
al.3 In the latter study, the stimuli to provoke the vasomotor response in the peripheral and 
coronary circulation were different and a different vascular bed was examined, i.e. conduc-
tance arteries. Alterations of epicardial artery diameter in response to intracoronary acetyl-
choline infusion were determined with quantitative coronary angiography (QCA), while the 
change in brachial artery diameter in response to reactive hyperemia in the peripheral circu-
lation was determined with vascular ultrasound. Thus, endothelial function of the epicardial 
artery was specifically tested with acetylcholine stimulation of the muscarinergic receptor, 
whereas flow-mediated brachial artery response was determined in response to hyperemic 
flow increases. In both the instances, the endothelial vasoreactivity of the conduit vessels of 
the periphery and coronary circulation was tested. This may explain the observed statistically 
significant but rather weak correlation between endothelium-dependent vasomotor re-
sponses at the site of conduit vessel of the peripheral and coronary circulation in patients 
with and without angiographically determined CAD (P = .36, P\.01) (Figure 1)3. Interestingly, 
this weak correlation appeared to be driven by patients without evidence of structural CAD. 
Conceptually, if these patients without evidence of structural CAD were taken out of the 
analysis, no association between peripheral and coronary endothelial function would proba-
bly exist. Thus, the results from Anderson et al3 suggest that CADrelated advanced struc-
tural alterations may actually dissolve the described association of endothelial function be-
tween the peripheral and coronary circulation. The prognostic value of the assessment of 
endothelial or vascular dysfunction of the peripheral and coronary circulation is well estab-
lished.4-6 In particular, the power of peripheral and coronary endothelial dysfunction in re-
sponse to various stimuli in the prediction of cardiovascular events appears to be compara-
ble.5 Cardiovascular events therefore may occur remotely from the site of endothelial dys-
function identified. These observations strongly suggest a systemic nature of vascular dys-
function and its central role in predicting future cardiovascular events. Vascular dysfunction 
has been appreciated as a useful integrating index of the overall stress burden by various 
cardiovascular risk factors on the arterial wall, taking into account the cumulative risk of car-
diovascular risk factors and as yet unknown variables and genetic predispositions.4,5,7 De-
spite this, it is   important to keep in mind that forearm conduit and resistance vessels do not 
develop atherosclerotic disease. 7 Currently, no systematic investigations of both the forearm 
and the coronary circulation have been performed, and therefore the relation between vaso-
motor function in the forearm and coronary circulation remains poorly understood. In this di-
rection, the observations from Scholtens et al1 shed some new light in that they did not ob-
serve an association between vasomotor function of the resistance vessels in the periphery 
and the coronary circulation when assessed concurrently with adenosine-induced hyperemic 
flow increases. Conversely, their study does not provide any mechanistic insight about the 
mechanisms underlying the vasoreactivity in the upper limb microcirculation in response to 
adenosine stimulation. Intravenous adenosine infusion caused a much lower flow increase in 
the upper limb than in the myocardium, which may be related to effectively lower adenosine 
arriving in the peripheripheral circulation and, at least in part, different mechanisms underly-
ing peripheral vasoreactivity.1 As regards the hyperemic myocardial blood flow increase dur-
ing pharmacologically induced vasodilation of the arteriolar vessels, vascular smooth muscle-
relaxing substances like adenosine, dipyridamole, or, more recently, adenosine receptor 
agonists decrease resistance to flow at the site of the coronary arteriolar resistance vessels 
and, thereby, cause a maximal or submaximal hyperemic myocardial blood flow increase.8,9 
The resulting hyperemic coronary flow increase is considered to represent predominantly an 
endotheliumindependent flow response as the aforementioned substances increase hypere-
mic flow increases through vascular smooth muscle cell relaxation at the site of the coronary 
arteriolar vessels.8,10 Blocking the endothelial nitric oxide synthase (eNOS) by intravenous 
infusion of NG-monomethyl-L-arginine, however, results into a significant loss of adenosine-
induced MBF increases by 20%-25% as measured with PET.9,11,12 It may be concluded 
that shear-sensitive components of the coronary endothelium contribute in part through a 
flow-mediated and, thus, nitric oxide-mediated coronary vasodilation to the overall hyperemic 
MBF increase during pharmacologic vasodilation.7,8,13 Such a myocardial flow response 
has also been appreciated as total integrated coronary circulatory function.8,9,14 The com-
plexity of the mechanisms underlying hyperemic MBF increases during pharmacologic vaso-
dilation may also explain, at least in part, the absence of any correlation between hyperemic 
myocardial and peripheral blood flows during pharmacological vasodilation with adenosine 
as determined with 13N-ammonia PET.1 Overall, the investigation by Scholtens et al1 add 
further to the consideration that vascular (dys)function in the peripheral and coronary circula-
tion may indeed reflect different features and stages of vascular disease. Given that the fore-
arm circulation does not develop atherosclerotic disease,7 systemic comparative investiga-
tions of endothelial, or circulatory dysfunction of both the forearm and the coronary circula-
tion and its response to pharmaceutical intervention15-19 could possibly contribute to better 
identify and characterize pathophysiological mechanisms favoring the initiation and progres-
sion of the CAD process and/or possible protective responses within the arterial wall aiming 
to counterbalance the adverse effects of various cardiovascular risk factors. Such an emerg-
ing concept certainly deserves further investigations. 
 
References 
 
1. Scholtens AM, Tio RA, Willemsen A, Dierckx RAJO, Boersma HH, Zeebregts CJ, et al. 
Myocardial perfusion reserve compared with peripheral perfusion reserve: A [13N]ammonia 
PET study. J Nucl Cardiol 2011. doi:10.1007/s12350-011-9339-2.  
2. Bottcher M, Madsen MM, Refsgaard J, Buus NH, Dorup I, Nielsen TT, et al. Peripheral 
flow response to transient arterial forearm occlusion does not reflect myocardial perfusion 
reserve. Circulation 2001;103:1109-14.  
3. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, et al. Close 
relation of endothelial function in the human coronary and peripheral circulations. J Am Coll 
Cardiol 1995;26:1235-41.  
4. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: A marker of atherosclerotic 
risk. Arterioscler Thromb Vasc Biol 2003;23:168-75.  
5. Lerman A, Zeiher AM. Endothelial function: Cardiac events. Circulation 2005;111:363-8.  
6. Rubinshtein R, Kuvin JT, Soffler M, Lennon RJ, Lavi S, Nelson RE, et al. Assessment of 
endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular 
adverse events. Eur Heart J. 2010;31:1142-8.  
7. Drexler H. Endothelial dysfunction: Clinical implications. Prog Cardiovasc Dis 1997;39:24-
287.   
8. Schindler TH, Schelbert HR, Quercioli A, Dilsizian V. Cardiac PET imaging for the detec-
tion and monitoring of coronary artery disease and microvascular health. JACC Cardiovasc 
Imaging 2010;3:623-40.  
9. Schindler TH, Zhang XL, Vincenti G, Mhiri L, Lerch R, Schelbert HR. Role of PET in the 
evaluation and understanding of coronary physiology. J Nucl Cardiol 2007;14:589-603.  
10. Valenta I, Quercioli A, Vincenti G, Nkoulou R, Dewarrat S, Rager O, et al. Structural 
epicardial disease and microvascular function are determinants of an abnormal longitudinal 
myocardial blood flow difference in cardiovascular risk individuals as determined with 
PET/CT. J Nucl Cardiol 2010;17:1023-33. 
11. Buus NH, Bottcher M, Hermansen F, Sander M, Nielsen TT, Mulvany MJ. Influence of 
nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia. 
Circulation 2001;104:2305-10.  
12. Tawakol A, Forgione MA, Stuehlinger M, Alpert NM, Cooke JP, Loscalzo J, et al. Homo-
cysteine impairs coronary microvascular dilator function in humans. J Am Coll Cardiol 
2002;40:1051-8.  
13. Drexler H, Zeiher AM, Wollschlager H, Meinertz T, Just H, Bonzel T. Flow-dependent 
coronary artery dilatation in humans. Circulation 1989;80:466-74.  
14. Schelbert HR. Anatomy and physiology of coronary blood flow. J Nucl Cardiol 
2010;17:545-54.  
15. Rubinshtein R, Yang EH, Rihal CS, Prasad A, Lennon RJ, Best PJ, et al. Coronary mi-
crocirculatory vasodilator function in relation to risk factors among patients without obstruc-
tive coronary disease and low to intermediate Framingham score. Eur Heart J 2010;31:936-
42.  
16. Munzel T, Sinning C, Post F, Warnholtz A, Schulz E. Pathophysiology, diagnosis and 
prognostic implications of endothelial dysfunction. Ann Med 2008;40:180-96.  
17. Schindler TH, Nitzsche EU, Munzel T, Olschewski M, Brink I, Jeserich M, et al. Coronary 
vasoregulation in patients with various risk factors in response to cold pressor testing: Con-
trasting myocardial blood flow responses to short- and long-term vitamin C administration. J 
Am Coll Cardiol 2003;42:814-22.  
18. Schindler TH, Cadenas J, Facta AD, Li Y, Olschewski M, Sayre J, et al. Improvement in 
coronary endothelial function is independently associated with a slowed progression of coro-
nary artery calcification in type 2 diabetes mellitus. Eur Heart J 2009;30:3064- 73.  
19. Schindler TH, Campisi R, Dorsey D, Prior JO, Olschewski M, Sayre J, et al. Effect of 
hormone replacement therapy on vasomotor function of the coronary microcirculation in 
postmenopausal women with medically treated cardiovascular risk factors. Eur Heart J 
2009;30:978-86.  
 
 
 
 
 
 
 
 
Figures: 
 
 
 
 
Figure 1. Brachial dilator response to reactive hyperemia as a function of the coronary re-
sponse to acetylcholine in patients without (circles) and with (squares) coronary artery dis-
ease (r = 0.36, P = .01) (with kind permission from Anderson et al3). 
